IO Biotech, Inc. IOBTQ
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $3.5M
- P/E
- 0.0×
Follow IOBTQ
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
2.01 | 1.96 | 2.32 | 3.33 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.73 | 0.93 | 1.65 | 2.23 | |
Debt/Assets |
41.71% | 15.88% | 0.00% | 0.00% | |
Debt/Equity |
18.29 | 4.22 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.21 | 0.76 | 1.03 | 0.63 | |
Capex/Depreciation |
(0.07) | (0.41) | (0.46) | (0.17) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.28) | (0.30) | (0.35) | (0.30) | |
Cash per Share |
0.46 | 0.43 | 0.56 | 0.91 | |
Shareholders Equity per Share |
0.01 | 0.02 | 0.40 | 0.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.01 | 0.02 | 0.40 | 0.71 | |
Free Cash Flow |
(18.48) | (19.85) | (23.10) | (19.64) | |
Working Capital |
18.52 | 19.08 | 24.06 | 45.47 | |
Capital Expenditures |
0.00 | (0.03) | (0.03) | (0.01) | |
Net Current Asset Value |
(2.21) | (1.75) | 23.03 | 44.27 | |
| Other line items | |||||
Quick Ratio |
1.67 | 1.41 | 2.03 | 3.08 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.28) | (0.30) | (0.35) | (0.30) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
5.42 | 5.28 | 4.52 | 4.27 | |
Average Assets |
64.95 | 76.90 | 86.95 | 109.21 | |
Average Common Equity |
36.74 | 48.93 | 70.94 | 90.09 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates